Cephalalgia : an International Journal of Headache
Overview
Cephalalgia is a renowned international journal dedicated to the study of headaches. It provides a platform for researchers, clinicians, and scientists to share their latest findings, advancements, and insights in the field. With a focus on all aspects of headache disorders, including diagnosis, treatment, and prevention, Cephalalgia serves as a valuable resource for professionals seeking to enhance their understanding and improve patient care in this complex and challenging area of medicine.
Details
Details
Abbr.
Cephalalgia
Start
1981
End
Continuing
Frequency
Twelve no. a year, 2004-
p-ISSN
0333-1024
e-ISSN
1468-2982
Country
United Kingdom
Language
English
Specialties
Neurology
Psychiatry
Psychiatry
Metrics
Metrics
h-index / Ranks: 1564
143
SJR / Ranks: 2233
1382
CiteScore / Ranks: 1286
10.50
JIF / Ranks: 1632
4.9
Recent Articles
1.
Melchior A, Al-Khazali S, Christensen R, Al-Khazali H, Ashina H
Cephalalgia
. 2025 Feb;
45(2):3331024251317595.
PMID: 40017062
Background: Occipital neuralgia (ON) describes severe, paroxysmal occipital nerve pain. This review synthesizes data on the epidemiology and clinical features of ON. Methods: A systematic search of PubMed and Embase...
2.
Asheer J, Ali F, Hilker R, Videbech P, Schytz H
Cephalalgia
. 2025 Feb;
45(2):3331024251317635.
PMID: 40017055
Background: Depression is frequently described to occur in migraine, and depression screening questionnaires are commonly used to evaluate depressive symptoms in patients with migraine. The present study aimed to investigate...
3.
Szabo E, Bolo N, Borsook D, Burstein R, Ashina S
Cephalalgia
. 2025 Feb;
45(2):3331024241313377.
PMID: 39995155
Background: In about half of migraine patients, anti-calcitonin gene-related peptide monoclonal antibodies reduce monthly migraine days by >50%. In these patients, this class of drugs may change cortical functions by...
4.
Liao Y, Tzeng Y, Chen S, Ling Y, Chen W, Wang S, et al.
Cephalalgia
. 2025 Feb;
45(2):3331024251317486.
PMID: 39988887
Background: The present study aimed to evaluate the risk and impact of fibromyalgia in relation to headache frequency in migraine patients. Methods: This cross-sectional study involved migraine patients from a...
5.
Combined effects of cannabidiol and Δ9-tetrahydrocannabinol alleviate migraine-like symptoms in mice
Zorrilla E, Krivoshein G, Kuburas A, Schenke M, Pina C, van Heiningen S, et al.
Cephalalgia
. 2025 Feb;
45(2):3331024251314487.
PMID: 39988876
Background: The therapeutic use of cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) to treat migraine has been understudied. Using three mouse models, we examined the impact of CBD and THC on migraine-relevant...
6.
Goadsby P, Jurgens T, Brand-Schieber E, Nagy K, Liu Y, Boinpally R, et al.
Cephalalgia
. 2025 Feb;
45(2):3331024251320610.
PMID: 39982105
Background: Published evidence supporting efficacy of calcitonin gene-related peptide receptor antagonists as acute migraine treatments in males is limited. Methods: To fill the gap, we present male and female data...
7.
Sacco S, Ashina M, Diener H, Haghdoost F, Lee M, Monteith T, et al.
Cephalalgia
. 2025 Feb;
45(2):3331024251320608.
PMID: 39980456
Migraine is one of the most prevalent and disabling neurological diseases, significantly affecting quality of life and productivity, as well as contributing to substantial societal costs. Recent innovations, including calcitonin...
8.
Navratilova E, Kopruszinski C, Oyarzo J, Barber K, Anderson T, Dodick D, et al.
Cephalalgia
. 2025 Feb;
45(2):3331024251321087.
PMID: 39980371
Background: Traumatic brain injury (TBI) commonly elicits acute (APTH) and/or persistent (PPTH) post-traumatic headache. Calcitonin gene related peptide (CGRP) has been implicated as a contributor to PTH pathophysiology. We explored...
9.
Guzman G, Kopruszinski C, Barber K, Lillo Vizin R, Dodick D, Navratilova E, et al.
Cephalalgia
. 2025 Feb;
45(2):3331024251317446.
PMID: 39945018
Background: Acute therapies targeting calcitonin gene-related peptide (CGRP) for episodic migraine (EM) demonstrate efficacy in women, but evidence of efficacy in men remains to be established. By contrast, CGRP targeting...
10.
Cheema S, Lagrata S, Rantell K, Ahmed M, Kamourieh S, Matharu M
Cephalalgia
. 2025 Feb;
45(2):3331024251317448.
PMID: 39924901
Background: New daily persistent headache (NDPH) is an often treatment-refractory primary headache disorder with a lack of evidence base for treatment. Methods: We performed an observational study using prospectively collected...